Medical Associates is now representing Hemosure, an innovative, non-invasive, who can be preformed at home or in a medical office.  The test is designed to screen for colorectal cancer, as well as lower GI diagnostic testing.   The test is Immunological Fecal Occult Blood Testing (IFOBT), which superior to the guiac test in many way.  
Presently endorsed by numerous medical societies due to many benefits of the test.  

Hemosure^®, an one-step, easy to use product developed by Hemosure, Inc. based on its years of clinical study, is the latest technological breakthrough in Immunological Fecal Occult Blood Testing (IFOBT), and it is both FDA approved and CLIA waived. Hemosure^® employs a unique combination of monoclonal and polyclonal antibodies to detect only human blood in stool. As a result, abstinence of food and drug before taking this test is no longer necessary. These advantages can significantly enhance patient compliances.

In addition to the inherent specificity and sensitivity, Hemosure^® test can be performed by health care providers in hospitals, labs and private practices. No need to send fecal samples to the laboratory.

Doctors can easily, quickly and accurately read the test results in less than 5 minutes. This new technology has greatly improved specificity, sensitivity, accuracy and cost-effectiveness of the fecal occult blood tests.

VA, MD, DC, DE & SE PA